KOBAYASHI PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,429 JPY | +0.15% |
|
-5.35% | -20.04% |
| May. 24 | Japan companies hog the spotlight as hedge funds tout their top Asia picks | RE |
| Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
ETFs positioned on Kobayashi Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 391 M€ | +7.63% | - | |
| 0.00% | 34 M€ | +7.50% | - | |
| 0.00% | 34 M€ | +3.86% | - | |
| 0.00% | 234 M€ | +8.48% | - | |
| 0.00% | 39 M€ | +5.00% | - | |
| 0.00% | 306 M€ | +5.07% | - | |
| 0.00% | 7 M€ | +0.11% | - |
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
Sector
Personal Products
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
5,429
JPY
Average target price
6,348
JPY
Spread / Average Target
+16.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -20.04% | 2.57B | |
| +12.28% | 388B | |
| +12.61% | 136B | |
| +16.62% | 76.27B | |
| -12.57% | 65.56B | |
| -15.65% | 44.23B | |
| -10.36% | 36.96B | |
| +6.37% | 35.04B | |
| +7.80% | 18.02B | |
| +12.30% | 15.57B |
- Stock Market
- Equities
- 4967 Stock
- Funds and ETFs Kobayashi Pharmaceutical Co., Ltd.
